FDA Releases Draft Guidance on Genetically Engineered Animals with Genome Editing Techniques

Summary

The US Food and Drug Administration (FDA) has published a draft guidance for industry (GFI) #187, which revises its previous guidance on genetically engineered animals and expands its scope to include animals intentionally altered using genome editing technologies, such as CRISPR.